Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: Porcine interferon lambda 3 (IFN-λ3) shows potent anti-PRRSV activity in primary porcine alveolar macrophages (PAMs)

Fig. 1

The CPE of primary PAMs treated with Porcine IFN-λ3 and infected with PRRSV. The primary PAMs were untreated or pre-treated with IFN-λ3 (10, 100, 1000 ng/ml). b The primary PAMs not treated. b The primary PAMs treated with 10 ng/ml IFN-λ3. c The primary PAMs treated with 100 ng/ml IFN-λ3. d The primary PAMs treated with 1000 ng/ml IFN-λ3. e Control primary PAMs. k The primary PAMs were treated or untreated with 100 ng/ml of IFN-λ3 for 12 h and then were infected with PRRSV NJ strain at 0.1 MOI. Infected cells were cultured for 12, 24, 36 or 48 h after infection. f, g, h, i, j corresponds to a, b, c, d, e with the same treatment. Magnifications, × 200

Back to article page